Know Cancer

or
forgot password

Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02)


N/A
18 Years
N/A
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information

Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02)


Inclusion Criteria:



- Age: >or=18 year-old

- Histologically (positive biopsy) proven prostate cancer with primary and secondary
Gleason patterns attributed.

- Patient planned to undergo radical prostatectomy

- Prostate cancer is deemed to be organ confined (T1-T2, Nx or No, Mx or Mo)

- No prior treatment for prostate cancer, including any type of hormonal therapy

- No major calcification is noted during the TRUS (i.e. (Diameter >or=5 mm, spread all
over the prostate or blocking to much of the ultrasound signal).

- Patient willing to give written informed consent

Exclusion Criteria:

- Patients who are either unsuitable or unwilling to enter the study or to proceed to
surgical investigation.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Harry Bleiberg, MD

Investigator Role:

Study Director

Authority:

Belgium: Ethics Committee

Study ID:

CR2P00113

NCT ID:

NCT01191931

Start Date:

February 2008

Completion Date:

June 2012

Related Keywords:

  • Prostate Cancer
  • Prostatic Neoplasms

Name

Location